Amlan International, the manufacturer of Calibrin enterosorbents, today announced that it has signed a distribution agreement with Elanco Animal Health to distribute its products in Japan.
Elanco Animal Health was founded in 1953 and is a global, innovation-driven company that develops and markets products to improve animal health and food-animal production in more than 75 countries. Elanco employs more than 2,300 people worldwide, with offices in more than
40 countries, and is a division of Eli Lilly and Company, a leading global pharmaceutical corporation. Elanco´s mission is to help the food industry produce an abundant supply of safe, nutritious, affordable food through enhanced animal health and herd-management practices.
Elanco is a trusted provider of high quality, safe and efficacious products for livestock. As Amlan's sole distributor in Japan, Elanco will market, sell and support the growth of Calibrin and other products offered by Amlan International.
Vice President of Amlan International, Ron Cravens said, "We are very pleased to have Elanco Japan join us in serving the livestock community. As a world leader in animal health products and science, Elanco's in-depth knowledge of disease management in the livestock industry will enhance our access to international markets for swine, poultry and dairy."
Mentioned in this news release: